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Abstract 
 
Storage of non-polar lipids in ubiquitous eukaryotic organelles, lipid droplets (LDs), 
prevents the toxic consequences of unesterified fatty acids and provides a lipid reservoir 
that can be promptly used to satisfy cellular needs under multiple metabolic and 
physiological conditions. Tight temporal and spatial control of LD biogenesis and 
mobilization of neutral lipids is essential for the correct channelling of lipid intermediates 
to their various cellular destinations and the maintenance of cellular homeostasis. These 
functions are mediated by multiple interactions between LDs and other intracellular 
organelles that are required for the delivery of stored lipids. Here we review recent 
advances in the interactions of LDs with the endoplasmic reticulum (ER), mitochondria 
and vacuole/lysosome. 
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1. Introduction 
 
The universal ability of eukaryotic organisms to store excess energy from nutrients in the 
form of non-polar or “neutral” lipids is essential for their survival when food sources are 
not readily available. At the cellular level, this storage takes place in specialized 
organelles called lipid droplets (LDs). What sets LDs apart from the majority of other 
intracellular organelles is their unique topology: they consist of a densely packed 
hydrophobic core of neutral lipids, mainly triacylglycerol (TG) and steryl esters (SE), and 
are surrounded by a phospholipid monolayer decorated by LD-associated proteins. 
During starvation, fatty acids released (“mobilized”) from LDs can be used for energy 
production via β-oxidation in mitochondria or peroxisomes. Moreover, neutral lipids stored 
in LDs play additional key roles: they can provide essential lipid precursors that are used 
for membrane biogenesis to support organelle or cell growth and can also act as a “sink” 
for toxic fatty acids that otherwise are lethal for cells. These functions depend on 
significant bidirectional intracellular exchange of several lipid species to and from LDs. 
This poses two major challenges for cells: firstly, as, to our knowledge, LDs are not 
connected to the general vesicular trafficking pathways, fatty acids and lipid species are 
probably exchanged exclusively through physical interactions with other organelles; and 
secondly, given the unique topology of LDs, the nature of these interactions is likely to be 
distinct from the canonical membrane contact sites (MCSs) that mediate lipid exchange 
between most other organelles. Indeed, while MCSs normally involve the close 
apposition of two phospholipid bilayers with an underlying aqueous lumen, LD-organelle 
interactions consist of a phospholipid monolayer coating a hydrophobic core contacting a 
bilayer with an aqueous lumen.  
 
Many features of LD biology have been recently discussed in several excellent reviews 
[1-5]. In this article we will review recent developments on how contacts between the LDs 
and the ER, mitochondria, peroxisomes or the vacuole/lysosome are established and 
regulated and elaborate on their functions on lipid metabolism. We focus on these 
specific organelles because, as discussed below, they are the most relevant for the 
biogenesis of LDs (ER) and the catabolism of their stored lipid (mitochondria, 
peroxisomes and vacuole/lysosome). 
 
2. LD-ER contact sites 
 
2.1 Anatomy and functions of LD-ER contact sites 
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Because the enzymes catalysing the biosynthesis of TGs and SEs (Figure 1) localize to 
the ER and the production of these neutral lipids is coupled to their storage, it is widely 
accepted that LDs emerge from the ER. Several recent studies in a diverse set of 
organisms have provided strong support for this model. However, the mechanisms 
underlying the early stages of LD emergence from the ER phospholipid bilayer and the 
nature of the association between the two organelles remain poorly defined. Biophysical 
studies propose that neutral lipids can be kept at low levels within the phospholipid 
bilayer, above which they undergo liquid-liquid phase separation (“de-mixing” or “oiling-
out”; reviewed in [6]); in vivo such a process could lead to the partitioning of the neutral 
lipid into the emerging LD that buds towards the cytoplasm. Ultrastructural studies on the 
nascent LD provide evidence that it forms a “lens” between the two leaflets of the ER 
bilayer, which would be consistent with a physical continuity between the two organelles 
[7, 8]. However, a different topology has been observed by freeze fracture studies where 
both leaflets of the ER appeared external to the LD and surround it in a “egg in a cup” 
manner [9]. During further expansion of LDs, driven by exogenous supplementation of 
oleate in fruitfly or mammalian cells, membrane contacts or “bridges” appear to link the 
LDs to the ER [10, 11] (Figure 2). Mature LDs in budding yeast appear to remain in 
contact with the ER [12-15]; in higher eukaryotes LDs remain in contact with the ER or 
dissociate from it [10, 11]. 
 
In addition to ultrastructural studies, evidence for a direct connection between the ER and 
LDs exists from several experiments examining the localization of the enzymes 
synthesizing neutral lipids during the biogenesis of LDs. Pioneering biochemical studies 
in budding yeast documented that enzyme activities responsible for neutral lipid synthesis 
can be detected in both the ER and LDs [16, 17]. Dga1, the enzyme that catalyzes the 
final acylation step in TG synthesis in yeast is an integral membrane protein that rapidly 
moves from the ER to the surface of LDs upon transcriptional induction of LD formation 
[14]. This movement was found to be reversible and independent of new protein 
synthesis, energy and temperature. In mammalian cells, induction of LD biogenesis by 
different means (oleate supplementation) also targets DGAT2, the ortholog of Dga1, to 
LDs [18, 19]. Oleate-loading of fly cells leads to the re-localization of the TG biosynthetic 
enzymes to a specific pool of LDs that appear to be connected to the ER membrane [11]. 
Other ER membrane enzymes with roles in LD homeostasis have been also shown to 
partition dynamically between the two organelles [20-22]. The mechanisms of membrane 
protein transport through ER-LD contacts have not been clarified. The hydrophobic core 
of LDs should preclude the insertion of integral membrane proteins with luminal domains, 
normally present in the ER. It has been suggested that hydrophobic “hairpin” domains, 
that can only partially cross the ER phospholipid bilayer, could be accommodated on the 
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LD phospholipid monolayer [23] (Figure 2).  In agreement with this model, disruption of 
the predicted “hairpin” topology of LD proteins blocks their translocation from the ER 
membrane [11, 21, 24, 25].  It should be noted that not all ER membrane proteins that are 
detected on LDs lack predicted luminal domains [26], so it remains unclear whether 
alternative modes to accommodate such proteins on LDs exist. A challenging 
combination of proteomics, immuno-EM and membrane biochemistry to determine 
protein topology is required to address the complexities of LD protein targeting. 
 
Whether similar to proteins, phospholipids can also traffic at the LD-ER interface remains 
unclear but has fundamental implications for LD biology. This is because LD 
phospholipids can critically regulate LD biogenesis: (1) the phospholipid monolayer that 
coats LDs is essential for solubilizing their hydrophobic core into the aqueous cytosol. 
Decrease of monolayer phospholipids leads to increased LD surface tension that results 
in their coalescence and consequently large or “supersized’ LDs. Consistently, genetic 
ablation of the synthesis of phosphatidylcholine (PC), the most abundant LD phospholipid, 
leads to the formation of supersized LDs in yeast, fly or mammalian cells [27-29]; an 
additional link between PC metabolism and LD morphology could be due to the fact that 
both PC and TG share common precursors [30] and thus, in the absence of PC synthesis, 
excess fatty acids could be re-directed into TG with consequences on LD content and 
morphology; (2) the phospholipid composition of LDs can also impact their protein 
composition: in addition to the enzymes that target LDs after inserting to the ER 
membrane, a second class of proteins associate with LDs directly from the cytosol. These 
employ amphipathic helices, a motif that separates hydrophobic from polar residues to 
the two opposite faces of the α-helix, in order to insert into the LD phospholipid 
monolayer. Accordingly, changes in phospholipid packing on the LD surface lead to the 
aberrant targeting of LD proteins [29, 31].  
 
Given the continuity at the ER-LD contacts, lateral diffusion of phospholipids through the 
apparent membrane “bridges” may provide a direct route for this traffic and ensure LD 
homeostasis when neutral lipids accumulate or are consumed in response to cellular 
metabolic changes. Seipin, an oligomeric protein that localizes specifically to the LD-ER 
contacts, and will be discussed in more detail below, could play a key role in this process, 
but the molecular details remain unknown. Alternatively, but not exclusively, 
phospholipids could be also synthesized and/or remodelled directly on the LD surface. 
According to this hypothesis, PC biosynthetic enzymes should be present on LDs. CCT1, 
the rate-limiting enzyme in the Kennedy pathway for PC synthesis (Figure 1), 
translocates to and associates with LDs via its amphipathic helix in D. melanogaster cells 
in response to oleate supplementation [29], although whether this translocation takes 
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place in mammalian cells is currently debated [32]. However, the enzyme catalyzing the 
following, and final, step in the Kennedy pathway is not present on LDs [21, 29]. 
Therefore, Kennedy pathway-derived PC likely requires a transport step from the ER in 
order to reach the surface of LDs. Alternatively, PC on LDs could be produced by the 
Lands cycle, a pathway that remodels PC acyl chains through acyl-
CoA:lysophosphatidylcholine acyltransferases  (LPCAT) 1 and 2 and which are active on 
LDs [21].  
 
The precise nature and composition of the membrane contacts between LDs and the ER 
remain elusive. However, there is evidence that modulation of the biophysical properties 
of LDs can control the formation of the contacts. Recruitment of the COP protein coat, 
that normally operates in the Golgi to ER vesicular transport pathway, on the surface of 
LDs by its activator Arf1, mediates the removal of surface phospholipids from LDs [33, 
34]. It was proposed that by increasing LD surfacing tension this process promotes the 
attachment of LDs to the ER membrane. Consistently, transport of ER membrane 
proteins to LDs was found to depend on Arf/COP1 in fly and mammalian cells [34-36].  
 
2.2 Seipin: gatekeeper of LD-ER contacts? 
 
Seipin is an evolutionarily conserved integral membrane protein that localizes to the LD-
ER contact site [12, 37, 38]. Recessive loss-of-function mutations in seipin are associated 
with severe Berardinelli-Seip congenital lipodystrophy type 2 (BSCL2), in which adipose 
tissue is almost completely absent [39]. The knowledge on how seipin controls LD 
morphology has increased in the past few years, with results from different model 
systems suggesting that seipin controls lipid and protein sorting to LDs to establish LD 
identity and maturation [31, 38, 40-44]. 
 
In yeast, seipin (Sei1, formerly known as Fld1) forms a complex with Ldb16, which 
requires Sei1 self-interaction and the transmembrane helices of both proteins [38]. 
Deletion of SEI1 or LDB16 result in two distinct types of LD morphology abnormalities: 
small clustered LDs enwrapped in ER or supersized LDs [12, 37, 38]. Although in a 
complex, mostly at the neck of LDs, overexpression of SEI1 or LDB16 cannot 
compensate for the loss of its partner, but deletion of both genes increase the frequency 
of cells with supersized LDs over small clustered lipid droplets [38, 41]. Overexpression 
of human seipin restores LD morphology in sei1Δ, ldb16Δ, or the double deletion strain, 
suggesting that during evolution human seipin alone has replaced the function of the 
Sei1-Ldb16 complex [38]. Interestingly, wild-type LD morphology is restored in sei1Δ 
mutant with the expression of human seipin or seipin neuronal seipinopathy mutants, but 
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not with most of seipin lipodystrophy mutants, which also fail to localise to LD-ER contact 
sites [12, 37, 38]. Aberrant LD morphology is also observed in Drosophila and human 
cells [42, 43], with initial accumulation of small nascent LDs in close proximity to the ER 
and subsequent formation of giant LDs at later stages during induction of LD biogenesis 
with oleic acid in seipin-depleted cells [43]. In human cells, a mutation that causes BSCL2 
fails to localize to LD-ER contact sites and leads to aberrant LD morphology [42]. 
Importantly, aberrant LDs in seipin mutants appear to correlate with structural defects at 
the LD-ER contacts sites: ldb16Δ mutants analysed by electron tomography display 
enlarged ER-LD contact sites, with ER protrusions enwrapping LDs and enlarged ER 
width not exclusively restricted to the contact site [31]. Similarly, in seipin-knockout 
human cells, LD-ER contact sites are more heterogeneous, with LDs showing extensive 
contacts sites or string-like bridges to the ER, or even absent. Moreover, the ER diameter 
widens when these cells are challenged with fatty acids [42]. Collectively, these data 
strongly support a role of seipin at LD-ER contact sites in controlling LD morphology. 
 
How does loss of seipin at LD-ER contacts disrupt LD structure? Studies on sei1Δ and 
ldb16Δ in yeast have provided important insights. Changes in phospholipid synthesis in 
these mutants, either by the addition of inositol, or by genetic manipulation of the pathway, 
resulted in the conversion of the supersized LDs into small clustered LDs [28, 31, 38, 40, 
44]. It has been previously reported that PC deficiency, caused by mutations in the 
phosphatidylethanolamine N-methyltransferase (PEMT) pathway (Figure 1) also results in 
the formation of supersized LDs [28, 37, 38] and that this can be rescued by induction of 
the parallel PC biosynthetic route, the Kennedy pathway, by adding its precursor choline. 
However, choline addition does not rescue the sei1Δ and ldb16Δ supersized LDs, 
suggesting that induction of phospholipid synthesis affects their LD structure via a distinct 
mechanism. Grippa et al (2015) [31] reported that small clustered LDs in sei1Δ and 
ldb16Δ cells were significantly enriched in PC and phosphatidylethanolamine (PE), the 
two most abundant phospholipids, despite the fact that their whole-cell lipid composition 
was the same as in wild-type cells. LD phospholipid changes were accompanied by 
severe perturbation of the LD proteome: resident LD proteins were lost while many 
amphipathic helix-containing proteins, including Pct1, the yeast orthologue of CCT1, 
targeted ectopically LDs. These results suggest that, in the absence of the Sei1-Ldb16 
complex, yeast cells cannot control the sorting of ER phospholipids to LD, which results 
in abnormal LD morphology and deregulated targeting of amphipathic helix-containing 
proteins, likely due to defects of phospholipid packing on LDs. Similarly, depletion of 
seipin in Drosophila and human cells has no major effect in cellular lipid metabolism but 
results in phospholipid deficiency in giant LDs [43]. Defects in protein targeting to LDs are 
also observed in seipin-deficient Drosophila and human cells [42, 43].  
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Another mechanism that could lead to the formation supersized LDs in seipin-deficient 
cells was recently proposed [45]. Seipin was shown to physically interact with glycerol-3-
phosphate acyltransferase (GPAT; Figure 1) to decrease its enzymatic activity both in 
yeast and humans; overexpression of yeast or human GPATs phenocopy the supersized 
LD phenotype of seipin-deficient cells, which can be prevented by co-overexpression of 
seipin. The supersized LD phenotype in seipin deficient human cells can be reverted by 
knocking down GPAT. Because GPATs catalyse the rate-limiting step in PA synthesis 
and the latter has been implicated in the formation of supersized LDs [28], it was 
suggested that high PA levels in the ER is the driver for the seipin phenotype [45].    
 
Seipin is also required for the early stages of LD biogenesis. In yeast, in an inducible de 
novo LD formation system, generation of LDs is delayed in the absence of Sei1, leading 
to accumulation of neutral lipids within membranes [40]. A short N-terminal segment in 
Sei1 is specifically involved in LD biogenesis initiation independently of the function of 
Sei1 in neutral lipid sorting. Similarly, seipin-depleted fly and mammalian cells show 
defects in the formation of initial LDs during oleate treatment, resulting in an aberrant 
accumulation of nascent LDs. Seipin-deficient cells have premature targeting and 
activation of the machinery required for LD expansion on nascent LDs, which results in 
the formation of giant LDs. Notably, in Drosophila and human cells, seipin shows a highly 
dynamic ER localization that becomes less mobile once it encounters a nascent LDs, with 
this interaction promoting its maturation into an initial LD [42, 43]. LDs from seipin-
knockout human cells also show increased mobility and aberrant multidirectional 
trajectories [42]. 
 
It remains unclear whether defects in sei1Δ or ldb16Δ mutants affect the cellular amounts 
of neutral lipids because different studies have reported opposite results [28, 38, 41]. 
However, overexpression of LDB16 in sei1Δldb16Δ cells restores TG levels under the 
conditions that lead to their reduction in this mutant. Since Ldb16 is degraded in sei1Δ 
cells and LDB16 overexpression cannot compensate for the loss of Sei1 in LD 
morphology [38], this indicates that Ldb16 likely plays a specific role, independently of 
Sei1, in TG synthesis [41]. Total TG levels do not seem to be affected in seipin-deficient 
cells in Drosophila [43], but neutral lipids decrease and lipid delivery is deficient in seipin-
knockout human cells [42]. 
 
The complexity of seipin mutant phenotypes likely reflects the multiple consequences of 
disrupting proper LD-ER attachments and the diversity of model systems used to study its 
function. The role of seipin on membranes at the molecular level remains unknown and 
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represents a major challenge for the future. Interestingly, seipin is known to form 
oligomers – of predicted nine or twelve subunits in yeast or humans, respectively – with a 
disk or toroid configuration [46, 47]. This structural organization may be required for lipid 
sorting and/or assembly of other factors interacting with seipin at LD-ER contact sites. 
Since LDs undergo dynamic changes in response to metabolic status in all organisms, 
the temporal and spatial regulation of seipin activity is likely to be critical for LD formation 
and function.  
 
2.3 LD-ER contacts and lipid compartmentalization in the ER 
 
There is evidence that the distribution of LD-ER contacts sites is not random and that the 
protein machinery involved in this process localizes to specific subdomains of the ER. 
This can be probed, for example, by following the localization of enzymes required for 
neutral lipids synthesis, an essential event during LD biogenesis. In yeast, Pah1 has 
been useful in the identification of these ER subdomains [44, 48]. Pah1 is a soluble 
cytosolic Mg2+-dependent phosphatidic acid (PA) phosphatase (PAP) that generates 
diacylglycerol (DG) used in TG synthesis ([49]; Figure 1). Pah1 activity requires 
dephosphorylation by the phosphatase complex Nem1-Spo7 [50], which mediates its 
association with membranes [51-53]. This dynamic association with membranes enables 
Pah1 to work as a ‘molecular switch’ to shift lipid intermediates towards TG synthesis 
when yeast cells exit logarithmic growth and initiate neutral lipid storage to LDs. Upon 
activation, Pah1 first localizes to nucleus-vacuole junctions (NVJ), an MCS established by 
the physical interaction of Nvj1 (on the nuclear envelope) and Vac8 (on the vacuole 
membrane) and is involved in piecemeal microautophagy of the nucleus [54]. Pah1 then 
moves to the perinuclear membrane subdomain flanking NVJ, where it concentrates on 
LD-ER contact sites [48]. By keeping Pah1 at the interface between the ER and LDs, 
cells may restrict the access of other ER phospholipid biosynthetic enzymes to the DG 
pool formed by Pah1. This could ensure the channelling of DG, a lipid that is at the 
crossroads of many pathways in the ER, towards storage in LDs and not membrane 
synthesis. Consistent with this hypothesis, yeast cells unable to make neutral lipids 
exhibit nuclear and ER membrane proliferation during post-diauxic shift phase, which can 
be partially rescued by ablation of phospholipid biosynthesis [48]. ER membrane defects 
of cells lacking LDs during nutrient starvation have been also reported [55, 56].  
 
Despite not formally addressed, several studies in budding yeast suggest that LDs 
accumulate at the ER subdomain flanking NVJ during stationary phase or other 
conditions that promote LD biogenesis. Whether this positioning enables the passage of 
LDs from the nuclear ER to the vacuole, where LDs are degraded at a later stage by 
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lipophagy (see chapter 4) or it performs another role at the nuclear envelope remains 
unknown. Moreover, in fission yeast TG-enriched LDs were also localized at the nuclear 
envelope [57]. Interestingly, loading mammalian cells with fatty acids induces LD 
clustering around the nucleus and, during starvation, dispersion of LDs to cell periphery is 
required for LD consumption and β-oxidation [58]. Moreover, complexes of ORP2 (an 
oxysterol-binding protein (OSBP)-related protein) and VAP (a vesicle-associated 
membrane protein (VAMP)-associated protein) at LD-ER contact sites favour TG 
synthesis and inhibit TG hydrolysis in human cells. These outcomes seem to be related 
to the spatial organization of LDs: overexpression of ORP2-VAP complexes induces the 
formation of LD clusters close to the nucleus, where TG synthesis may be facilitated; and 
silencing of the complex enhances TG mobilization, presumably by facilitating the 
movement of LDs to regions that favour TG hydrolysis [59]. Because mobilized fatty acids 
can be also used for membrane biogenesis [60], the positioning of LDs within the ER 
network could be important to support localized organelle biogenesis. One relevant 
example comes from sporulation (gametogenesis) of yeast cells: during this process, LDs 
move from the vacuole towards the nucleus where they form clusters. Interestingly, 
lipolysis from a specific pool of LDs that are in contact with the forming prospore 
membrane - a double membrane vesicle that sequesters the four meiotic nuclei – is 
thought to contribute to its expansion and, consequently, spore development, by 
providing fatty acids and other lipid precursors [61, 62]. 
 
The role of Pah1 in LD biogenesis is likely not restricted to TG production. In fact, pah1Δ 
mutants contain significantly fewer LDs despite that their total levels of TG and steryl 
esters combined together, are similar [63]. Interestingly, deletion of DGK1 – which 
encodes for the diacylglycerol kinase that mediates the reverse reaction of Pah1 – 
suppresses LD defects in pah1Δ cells [63-65]. Therefore, the levels of PA and DG at LD-
ER contact sites may be critical for LD biogenesis. A number of observations in yeast are 
consistent with this model: LD biogenesis is induced by an increase in DG levels in cells 
that lack neutral lipids and express the heterologous LD scaffolding proteins perilipins or 
oleosin [66]; mutants with increased PA levels show supersized LDs [28]; and fluorescent 
PA-binding reporters accumulate at LD-ER contact sites in seipin-deficient yeast cells 
during (or perhaps due to) LD formation [41, 44]. PA-binding reporter accumulation is not 
observed in sei1Δldb16Δ cells expressing human seipin, which suggests that modulation 
of PA levels at LD-ER contact sites is a conserved function of seipin [41]. However, 
overexpression of enzymes that metabolize PA fail to reduce the targeting of the PA-
binding reporters at LD-ER junctions in sei1Δ cells [41]. Furthermore, accumulation of PA 
reporters is still observed under growth conditions that favour PA consumption [31], 
suggesting that their targeting to LD-ER contacts may be independent of PA. Alternatively, 
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these observations could also be explained by the inaccessibility of this PA pool to PA 
metabolizing enzymes. Elevated PA levels, caused by the overexpression of DGK1, 
induce the recruitment of the PA phosphatase Pah1 to the nuclear membrane that is in 
association with the nucleolus [51] and both Pah1 and Nem1 target LD-ER contact sites 
in seipin mutants at the nuclear membrane [41, 44], further reinforcing the notion of PA 
accumulation at this subdomain. PA accumulation due to overexpression of DGK1 leads 
to expansion of the nuclear/ER membrane [51, 64], and seipin-deficient cells also show 
ER expansion enwrapping LDs in yeast [13, 31, 44] and LDs surrounded by ER in human 
cells [42]. These observations highlight the central role of LD biogenesis in ER 
morphology; the exact origin and nature of these membranes has not been yet identified 
but their characterization will help define the specific subdomains of the ER involved in 
LD-ER contact sites and consequently in LD formation.  
 
3. LD-vacuole/lysosome interactions 
 
The relationship between LDs and the vacuole (in yeast) or the lysosome (in higher 
eukaryotes) is probably best exemplified by the reciprocal interaction of LDs with 
autophagy. Degradation of LDs by autophagy  – a process called lipophagy – is 
evolutionarily conserved but it proceeds through distinct mechanisms: macroautophagy 
(in mammals) and microautophagy (in yeast). Following the initial observation that small, 
and portions of larger, LDs can be sequestered by the autophagosome for degradation 
through macroautophagy [67] (Figure 3a), many studies have reported an accumulation 
of LDs due to genetic/pharmacological inhibition of autophagy in different cells types. 
Reciprocally, increased autophagy leads to clearance of LDs, which may prevent 
pathologies such as fatty-liver disease [68]. Therefore, in order to obtain a 
comprehensive understanding of lipophagy, it will be important to characterize the 
molecular machinery playing a direct role in this process. This includes, for example, 
proteins that associate with LDs during lipophagy, such as the small GTPase Rab7. 
Under basal conditions, perilipin 1 on the surface of LDs prevents the association of Rab7 
with this organelle. However, β-adrenergic receptor stimulation increases the 
translocation of Rab7 to LDs, which stimulates lipophagy [69]. Activation of Rab7 during 
nutrient stress also mediates the physical interaction of LDs with degradative 
compartments to promote lipophagy [70]. Interestingly, in yeast cells, the Rab7-like 
protein Ypt7 – a late endosome and vacuolar marker – shows a partial colocalization with 
LDs and is found in the proteome of isolated LDs. Cells lacking Ypt7 show an increase in 
the number of LDs and total cellular lipid fatty acid content, and abnormal LD morphology, 
which is consistent with a role for Ypt7 in LD dynamics. [71]. Similar to Rab7, the 
chromosome 19 open reading frame 80 (C19orf80) also associates with LDs to promote 
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lipophagy during thyroid hormone stimulation [72]. Interestingly, autophagy can also fuel 
the biogenesis of LDs by releasing fatty acids from membranes that can be re-esterified 
and stored as neutral lipids (Figure 3b, [73]). 
 
Notably, LDs also affect autophagy (Figure 3). Indeed, in mammalian cells, an increase in 
LD biogenesis, by treating the cells with oleate, enhances autophagy initiation and 
maturation, with multiple interactions of LDs with autophagic organelles [74]; and, in yeast, 
autophagy is inhibited at early stages of autophagosome biogenesis in cells defective in 
neutral lipid synthesis [55, 75]. A role of neutral lipids in autophagy was supported by the 
identification of lipases involved in the formation of autophagosomes (Figure 3c). In 
mammalian cells, the neutral lipase PNPLA5 mobilizes TG to generate DG used for PC 
synthesis that contributes for the formation of membranes for autophagosomes [74]. 
Similarly, in yeast, the steryl-ester hydrolase Yeh1, the TG lipase Ayr1 and the serine 
hydrolase Ldh1 (that also displays both steryl-ester hydrolase and weak TG lipase 
activities) are required for autophagy during nitrogen starvation [55]. Interestingly, LDs 
are not required for rapamycin-induced autophagy [56, 76]; and in LD-deficient cells, the 
inhibition of fatty acid synthesis or the modulation of ER phospholipid composition 
improves starvation-induced autophagy and cell survival. Therefore, during starvation, 
cells unable to make neutral lipids increase phospholipid synthesis (particularly 
phosphatidylinositol) to buffer excess fatty acids, and these changes in ER phospholipid 
composition compromise autophagy [56]. Collectively, these results suggest that LDs 
may contribute to membrane synthesis used for autophagosome formation and ER 
homeostasis to ensure normal regulation of autophagy. 
 
In yeast, LDs are degraded in the vacuole, in a process that resembles microautophagy 
(Figure 4), during nitrogen starvation [77], stationary-phase [78], and lipid-stress-induced 
ER stress [79]. Although the association of LDs with the vacuole membrane is 
morphologically similar, these conditions trigger to some extent different types of 
lipophagy. Indeed, while nitrogen-starvation- and stationary-phage-induced lipophagy 
requires the core autophagy machinery [77, 78], at least Atg7 is dispensable for lipid-
stress-induced lipophagy [79]. Also, stationary-phase lipophagy requires the association 
of LDs with a sterol-enriched liquid-ordered domain on the vacuolar membrane [78], 
which is not formed during nitrogen-starvation [80]. Interestingly, this sterol-enriched 
liquid ordered domain is excluded from NVJ during Pah1 recruitment to this contact site 
[48], and Nem1 is required for the formation of the domains [78, 80]. This suggests that 
LD biogenesis and the formation of the domains are linked. The concentration and 
coordination of their molecular machinery at NVJ may have an impact in stationary-phase 
lipophagy by controlling the organization of LDs at this perinuclear-ER subdomain and 
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lateral movement to the vacuole. Interestingly, the disruption NVJ does not hamper but 
actually modestly increases stationary-phase lipophagy [81]. This may be due to a 
negative effect of NVJ on the lateral movement of LDs to the vacuole, or a consequence 
of a compensatory mechanism of other ER-vacuole contact sites in response to loss of 
NVJ.  
The mechanisms responsible for the mobilization of the neutral lipids delivered to the 
vacuole by lipophagy remain obscure. During nitrogen-starvation induced lipophagy, the 
lipase Atg15 is responsible for most of this activity, which provides fatty acids for growth 
when the de novo fatty acid biosynthesis is inhibited [77]. Since lipophagy is required for 
the formation of sterol-enriched liquid-ordered domains in the vacuole – most likely by 
releasing sterols stored in steryl-esters – and these are absent in Atg15-deficient cells 
[78], it is likely that this lipase also operates during stationary-phase lipophagy. Cells 
likely coordinate neutral lipid mobilization because yeast cells lacking Atg15 increase 
lipolysis by cytosolic TG lipases Tgl3 and Tgl4 [82].  
 
Several aspects of lipophagy require significant further clarification (Figure 4). What is the 
fate of the lipids degraded in the vacuole/lysosome? Is lipophagy used as an alternative 
route to provide fatty acids and/or other lipids under metabolic conditions that hamper de 
novo biosynthesis, as previously suggested [77]? If so, what is the advantage for cells of 
using lipophagy over lipolysis? Could the type of LD degradation be influenced by their 
spatial organization in cells? What is the machinery required for lipid export from the 
vacuole/lysosome and does it involve membrane contact sites? The existence of multiple 
contact sites between the vacuole and the ER [83], and between the vacuole and 
mitochondria (vCLAMP; [84, 85]) suggest that this may be the case. Interestingly, 
vCLAMP depends on the HOPS subunit Vps39 and Ypt7 that, as described above, are 
involved in LD dynamics [71]. Alternatively, fatty acids may be exported from the vacuole 
to the cytosol through an unidentified mechanism, involving their conversion into acyl-
CoA, followed by trafficking to specific compartments such as the peroxisome (for β-
oxidation) or the ER. In addition to fatty acids, other products of vacuolar lipolysis may 
use similar pathways for lipid recycling. As mentioned above, turnover of SE likely 
provides ergosterol for the formation of sterol-rich microdomains during stationary-phase 
lipophagy. 
Finally, lipophagy may also play a role in the degradation of protein aggregates: it was 
shown in yeast that chaperones are recruited to LDs enriched in ubiquitinated proteins, 
presumably misfolded ER proteins, during lipid stress [79]. Further work is required to test 
whether this precedes clearance of these specific LDs by lipophagy. 
 
4. LD-mitochondria and LD-peroxisomes interactions 
	   14	  
 
Conversion of fatty acids into acetyl-CoA through β-oxidation in mitochondria (in 
metazoans) or peroxisomes (in yeast and plants) is one of the fates of lipids stored in LDs. 
Therefore, a close interplay must take place between LDs and these organelles to ensure 
the coordination between lipolysis and trafficking of fatty acids to mitochondria or 
peroxisomes. Indeed, TG lipolysis mediated by adipose triglyceride lipase (ATGL) 
positively regulates SIRT1 to induce the expression of genes involved in β-oxidation and 
mitochondrial biogenesis [86, 87]. In a similar mechanism, ATGL promotes mitochondrial 
function in islet β cells, which is required for glucose-stimulated insulin secretion [88]. 
Catabolism of LD-derived fatty acids may proceed through contact sites between LDs 
and mitochondria or peroxisomes. In fact, LDs can be found close to mitochondria in 
oxidative tissues with high demand of fatty acids for energy production [89]; and, in yeast, 
stable contacts between LDs and peroxisomes, called ‘pexopodia’, contain enzymes 
required for β-oxidation and may presumably facilitate the transfer of fatty acids between 
these organelles [90]. Interestingly, TG mobilization negatively regulates LD-peroxisome 
physical interactions in Arabidopsis thaliana [91, 92]. Using bimolecular fluorescence 
complementation assays in yeast, Pu et al (2011) have provided evidence of physical 
interactions between LDs and mitochondria or peroxisomes. Since most of the interacting 
proteins are enzymes or proteins involved in transport, these results suggest a role for 
these contact sites in metabolism and trafficking. Because β-oxidation occurs in 
peroxisomes in yeast, these findings indicate that LD-mitochondria contact sites may also 
be involved in other processes [93]. Furthermore, perilipin 5 promotes the physical 
association of mitochondria with LDs through its C-terminal region in oxidative tissues, 
thus controlling mitochondrial fatty acid exposure and utilization [94, 95]. Tight physical 
interactions between LDs and mitochondria in mouse interscapular brown adipose tissue 
are further highlighted by the presence of mitochondrial proteins in the proteome of 
isolated LDs. The levels of some of these mitochondrial proteins change with cold 
treatment, which may reflect the dynamics of LD-mitochondria interaction for fatty acid 
utilization in thermogenesis [96].  
 
Recent studies have provided some intriguing insight on the physiological signals that 
regulate LD-mitochondria associations. Transient LD-mitochondria (kiss-and-run) and 
stable contacts increase during starvation and depend on microtubule-mediated 
dispersion of these organelles to the cell periphery, which is required for LD consumption 
and fatty acid β-oxidation. The spatial organization of LDs (and mitochondria) under 
these conditions is promoted and maintained by detyrosinated microtubles due to AMPK 
activation [58]. During starvation, fatty acids derived from lipolysis are transferred to 
mitochondria in close proximity with LDs while autophagy recycles fatty acids from 
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membranes to maintain neutral lipid stores (Figure 3b). As LD-mitochondria associations 
are limited, efficient fatty acid catabolism relies on mitochondrial fusion for a homogenous 
distribution of fatty acids through the mitochondrial network. To avoid toxic effects due to 
mitochondrial fusion defects, fatty acids are re-esterified and stored in LDs or exported to 
the extracellular medium [73]. Consistently, cells deficient in proteins required for 
mitochondrial fusion show fewer but larger LDs when grown in the presence of oleate [97]. 
 
LD-mitochondria interactions are not only required for channelling fatty acids for oxidation 
but also for proper LD biogenesis and stability. Indeed, PEMT (which methylates PE into 
PC), DGAT2 (responsible for DG acylation into TG) and MGAT2 (which catalyses the 
production of DG and is in a complex with DGAT2, Figure 1) are found in mitochondria-
associated ER membranes (MAM) in close association with LDs [19, 98, 99]. In fact, a 
murine DGAT2 mutant that mis-localises to mitochondria but not ER retains the ability to 
promote TG storage [100]. During adipogenesis in murine cells, mitochondrial-derived PE 
is used by PEMT to make PC on LDs, contributing to LD growth. PEMT-driven PC 
synthesis also affects perilipin A association with LDs, which impacts on LD stability by 
controlling lipolysis [98]. Taken together these observations support a close interaction 
between, LDs and mitochondria/peroxisomes that mediate bidirectional lipid traffic 
between these organelles. Whether specific protein machinery exists to tether these 
organelles and facilitate lipid traffic or whether traffic takes place through a common 
proximal ER domain, with which these organelles associate, remains unknown.  
 
Fatty acid activation and transacylation.  
 
Fatty acids need to be thioesterified with coenzyme A (CoA), both for their storage in LDs 
as well as for their utilization by mitochondria and peroxisomes following their release 
from LDs (Figures 1 and 2). The formation of these acyl-CoAs is mediated by acyl-CoA 
synthetases (ACS). Previous reviews have comprehensively addressed the role of these 
enzymes in fatty acid compartmentalization in different tissues [101, 102]. Here we will 
briefly discuss how ACS might coordinate fatty acid channelling in the context of LD 
interactions with other organelles.  
To our knowledge, there is no evidence of a specific enrichment of ACS in LD-organelle 
contact sites. In fact, the determination of the subcellular localization of these enzymes 
has been hampered by organelle contamination in subcellular fractionation studies (e.g., 
ER contamination of LD fractions) and low expression levels in microscopy analyses 
[102]. Despite these limitations, examples of associations of ACS with other organelles 
include LDs [103-106], mitochondria [107, 108], and peroxisomes [109, 110]. The 
subcellular localization and function of these enzymes may vary between cell types and 
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be subject to transient associations under specific conditions. For example, this is the 
case of ASCL3, which localises both to ER and LDs in a cell- and FA-specific manner 
[105]. ACS on LDs may directly activate fatty acids released during lipolysis or, 
alternatively, the close proximity promoted by LD-organelle interactions may facilitate 
fatty acid activation by ACS present on mitochondria and peroxisomes.  
 
Fatty acids can also be directly transferred from phospholipids to DG by 
phospholipid:diacylglycerol acyltransferases (PDATs), or to sterols, by lecithin:cholesterol 
acyltransferase (LCATs), in an acyl-CoA independent manner. Fungi, green algae and 
plants, express several PDATs, and are therefore able to produce TG directly from 
phospholipids. Lro1 is responsible for the PDAT activity in S. cerevisiae and transfers sn-
2 acyl groups from PE and PC to DG [111-113]. The C. reinhardtii PDAT mediates TG 
synthesis, which is coupled to chloroplast membrane turnover in response to stress [114]. 
How membrane-derived fatty acids would be channelled to LDs, remains unknown. It also 
remains to be clarified whether in mammals, and other organisms, that lack apparent 
PDAT-related proteins, phospholipase activity coupled to ACS-mediated fatty acid 
activation may replace PDAT function; there is evidence that during stress, mammalian 
cells induce TG synthesis and LD biogenesis that depends on phospholipase A2 [115]. 
Finally, both Lro1 and Dga1 in budding yeast, and the human PLA2 PLA2G15 can also 
acylate ceramide [116-118], and acylceramide produced by DGAT2 can also be stored in 
LDs [119]. 
 
5. Conclusion and perspective 
The essential roles of LDs in membrane biogenesis or energy production can be 
performed only through their regulated release and delivery of lipids to other intracellular 
organelles. At the same time, LDs receive extensive protein and lipid traffic from the ER 
and mitochondria, which is critical for their formation and stability. Because this 
bidirectional cross talk must be precisely coordinated with the metabolic status of cells, 
the interactions of LDs with other organelles need to be highly dynamic.  
 
In most cell types, LDs are stably connected to the ER, which extends throughout the cell 
contacting most other organelles. Therefore, the positioning and dynamics of LDs within 
the ER network could influence their interaction with other organelles. Whether machinery 
mediating direct contact between LD and mitochondria or peroxisomes, where mobilized 
fatty acids are catabolized, exists, remains also unknown. This raises also the question of 
whether mobilized lipids from LDs traffic to these organelles through LD-ER contacts. 
Several exciting advances have been made in the last few years on seipin; however, 
details on its precise molecular function at LD-ER contacts are still missing and may 
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require the development of new in vitro assays to follow LD assembly in phospholipid 
bilayers. Finally, LDs show a much broader spectrum of organelle associations than 
originally thought, which include “homotypic” LD-LD contacts that control neutral lipid 
transfer in specialized cell types such as adipocytes, as well as components of the 
endocytic pathway, the plasma membrane in the form of caveolae, bacterial and viral 
pathogens and more recently the intra-nuclear compartment. Determining how LD-
organelle interactions are brought by and regulated will be an important and stimulating 
challenge for the future.  
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Figure legends 
 
Figure 1. Simplified schematic representation of the pathways involved in the synthesis 
of phospholipids and triacylglycerol. Common steps are represented in gray, the Kennedy 
pathway in blue, and other phospholipid synthesis pathways in orange. Dashed arrows 
represent steps presented in yeast but not in humans. Relevant enzymes discussed in 
the text are highlighted in bold. The orange inset highlights phospholipid synthesis at 
mitochondria-ER contact sites, and the dashed inset shows fatty acid activation by acyl-
CoA synthetases. FA, fatty acid; lyso-PA, lyso-phosphatidic acid; PA, phosphatidic acid; 
DG, diacylglycerol, TG, triacylglycerol; PC, phosphatidylcholine; PE, 
phosphatidylethanolamine; PS, phosphatidylserine; Cho, choline; P-Cho, 
phosphocholine; CDP-Cho, cytidine diphosphate-choline; Etn, ethanolamine; CDP-Etn, 
cytidine diphosphate-ethanolamine; GPAT, glycerol-3-phosphate acyltransferase; AGPAT, 
acylglycerophosphate acyltransferase; PAP, phosphatidic acid phosphohydrolase; DGAT, 
diacylglycerol acyltransferase, CCTα, Choline-phosphate cytidylyltransferase; PEMT, 
phosphatidylethanolamine N-methyltransferase; PSD, phosphatidylserine decarboxylase, 
PSS, Phosphatidylserine synthase; ACS, acyl-CoA synthetases. 
 
Figure 2. Model of LD-ER contact site structure and function. Contact sites provide a 
route for membrane-associated proteins (in red) to translocate from the ER onto the 
surface of the LDs. This is thought to involve hydrophobic “hairpins” that can only span 
part of the ER phospholipid bilayer. Contact sites may also allow traffic of PC (in green) 
or other ER phospholipids by lateral diffusion to the surface of the LD and mediate its 
coordinated expansion during neutral lipid storage. Seipin, (or the Sei1-Ldb16 complex in 
yeast), localizes to LD contacts sites and has been proposed to control this process 
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although molecular details remain unknown. Pah1, a PA phosphatase that generates DG, 
localizes to LD-ER contacts and may be required for both TG synthesis and LD 
biogenesis. Whether in addition to its synthesis on the surface of LDs, TG can be also 
channeled from the ER through LD-ER contacts, remains unknown. SE synthesis is also 
important for LD biogenesis, but the mechanisms underlying its packaging at LD-ER 
contacts are unknown. 
 
Figure 3. Interactions of LDs with lysosome/vacuole. (a) Degradation of small or portions 
of larger LDs by the lysosome involves proteins that associate with LDs during lipophagy, 
such as Rab7 and C19orf80. (b) Degradation of cellular membranes during autophagy 
may provide FAs for LDs biogenesis. (c) Neutral lipids stored in LDs may be released by 
specific lipases, in mammalian and yeast cells, that can be then used for membrane 
synthesis during autophagosome formation. See chapter 3 for details.  
 
Figure 4. Lipophagy in yeast. In yeast, lipophagy resembles microautophagy. During 
stationary-phase (Stat-phase), LDs accumulate in an ER subdomain flanking nuclear-
vacuole junctions (NVJ) and the membrane of the vacuole is organized in two 
subdomains. In Stat-phase lipophagy, LDs associate with sterol-rich microdomains for 
vacuole internalization, which does not happen during lipophagy induced by nitrogen 
starvation. However, both require the core autophagy machinery. Degradation of LDs in 
the vacuole likely involves the lipase Atg15, and the ergosterol released may promote the 
formation of the sterol-rich microdomains. Lipid intermediates released during lipophagy 
are expected to be channeled to other cellular compartments – through unidentified 
transporters or organelle contact sites, depicted in blue in the figure – where they may be 
used for phospholipid synthesis or energy production. Inset: micrograph of a yeast cell in 
the post-diauxic shift phase, co-expressing ER (green) and vacuolar (red) reporters. Lipid 
droplets are labelled in blue with monodansylpentane. The outline of the cell is depicted; 
bar, 2.5 µm. 
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